BSGM logo

BioSig Technologies (BSGM) EBITDA

Annual EBITDA

-$28.15 M
-$1.18 M-4.37%

December 31, 2023

Summary

Performance

1-Year Change

-4.37%

3-Year Change

+52.36%

5-Year Change

-63.2%

15-Year Change

-118.32%

BSGM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.89%
BSGM annual EBITDA is higher than 44.89% of companies in Healthcare sector

High & Low

All-time High

-$6.22 M

3-Year Low

-$33.21 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BSGM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 20, 2025
BSGM next annual earnings announcement is scheduled for May 20, 2025

OtherBSGMprofitabilitymetrics:

Annual Revenue

$18.00 K
BSGM annual revenue is $18.00 thousand

Annual Net Income

-$29.04 M
BSGM annual net profit is -$29.04 million

Annual EBIT

-$28.51 M
BSGM annual earnings before interest & taxes is -$28.51 million

Annual EPS

-$3.95
BSGM annual earnings per share is -$3.95

Quarterly EBITDA

-$2.92 M
+$938.00 K+24.32%

September 30, 2024

Summary

Performance

3-Month Change

+24.32%

1-Year Change

+51.94%

3-Year Change

+57.79%

5-Year Change

+57.79%

BSGM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.2%
BSGM quarterly EBITDA is higher than 57.2% of companies in Healthcare sector

High & Low

All-time High

-$584.40 K

3-Year Low

-$10.82 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BSGM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 20, 2025
BSGM next earnings announcement is scheduled for May 20, 2025

OtherBSGMprofitabilitymetrics:

Quarterly Revenue

-
BSGM quarterly revenue value is unknown

Quarterly Net Income

-$1.91 M
BSGM quarterly net profit is -$1.91 million

Quarterly EBIT

-$2.95 M
BSGM quarterly earnings before interest & taxes is -$2.95 million

Quarterly EPS

-$0.12
BSGM quarterly earnings per share is -$0.12

TTM EBITDA

-$16.18 M
+$1.04 M+6.04%

September 30, 2024

Summary

Performance

3-Month Change

+6.04%

1-Year Change

+42.51%

3-Year Change

+40%

5-Year Change

+40%

BSGM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.98%
BSGM TTM EBITDA is higher than 53.98% of companies in Healthcare sector

High & Low

All-time High

-$1.22 M

3-Year Low

-$33.21 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BSGM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 20, 2025
BSGM next earnings announcement is scheduled for May 20, 2025

OtherBSGMprofitabilitymetrics:

TTM Revenue

-
BSGM TTM revenue value is unknown

TTM Net Income

-$15.28 M
BSGM TTM net profit is -$15.28 million

TTM EBIT

-$16.43 M
BSGM TTM earnings before interest & taxes is -$16.43 million

TTM EPS

-$1.40
BSGM TTM earnings per share is -$1.40

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$28.15 M
BSGM annual EBITDA is -$28.15 million

Annual Net Income

-$29.04 M
BSGM annual net profit is -$29.04 million

Annual Interest Expense

-
BSGM annual interest expense value is unknown

Annual Income Tax

$0.00
BSGM annual income tax is $0.00

Annual D&A

$361.00 K
BSGM annual depreciation & amortization is $361.00 thousand

BSGM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.4%+51.9%+42.5%
3 y3 years+52.4%+57.8%+40.0%
5 y5 years-63.2%+57.8%+40.0%

BSGM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.4%+15.2%at high+73.0%at high+51.3%
5 y5-year-4.4%+52.4%at high+86.9%at high+74.2%
alltimeall time-352.5%+52.4%-399.5%+86.9%-1226.0%+74.2%

BioSig Technologies EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.92 M(-24.3%)
-$16.18 M(-6.0%)
Jun 2024
-
-$3.86 M(+15.7%)
-$17.22 M(-28.8%)
Mar 2024
-
-$3.33 M(-45.1%)
-$24.18 M(-14.1%)
Dec 2023
-$28.15 M(+4.4%)
-$6.07 M(+53.4%)
-$28.15 M(-2.9%)
Sep 2023
-
-$3.96 M(-63.4%)
-$28.99 M(-7.8%)
Jun 2023
-
-$10.82 M(+48.1%)
-$31.43 M(+19.7%)
Mar 2023
-
-$7.30 M(+5.6%)
-$26.26 M(-2.6%)
Dec 2022
-$26.97 M(-18.8%)
-$6.92 M(+8.0%)
-$26.97 M(-7.0%)
Sep 2022
-
-$6.40 M(+13.4%)
-$29.00 M(-4.4%)
Jun 2022
-
-$5.64 M(-29.5%)
-$30.35 M(-7.2%)
Mar 2022
-
-$8.01 M(-10.4%)
-$32.70 M(-1.5%)
Dec 2021
-$33.21 M(-43.8%)
-$8.94 M(+15.4%)
-$33.21 M(-5.6%)
Sep 2021
-
-$7.75 M(-3.1%)
-$35.17 M(-12.9%)
Jun 2021
-
-$8.00 M(-6.1%)
-$40.39 M(-26.0%)
Mar 2021
-
-$8.52 M(-21.9%)
-$54.60 M(-7.1%)
Dec 2020
-$59.09 M(+72.8%)
-$10.90 M(-15.9%)
-$58.75 M(-6.3%)
Sep 2020
-
-$12.96 M(-41.6%)
-$62.71 M(+13.5%)
Jun 2020
-
-$22.21 M(+75.3%)
-$55.24 M(+34.7%)
Mar 2020
-
-$12.67 M(-14.8%)
-$41.01 M(+19.9%)
Dec 2019
-$34.20 M(+98.3%)
-$14.87 M(+171.2%)
-$34.20 M(+36.6%)
Sep 2019
-
-$5.48 M(-31.3%)
-$25.03 M(+10.3%)
Jun 2019
-
-$7.98 M(+36.0%)
-$22.70 M(+10.8%)
Mar 2019
-
-$5.87 M(+2.9%)
-$20.48 M(+18.7%)
DateAnnualQuarterlyTTM
Dec 2018
-$17.25 M(+33.8%)
-$5.70 M(+81.0%)
-$17.25 M(+3.8%)
Sep 2018
-
-$3.15 M(-45.4%)
-$16.62 M(+8.1%)
Jun 2018
-
-$5.76 M(+118.8%)
-$15.38 M(+21.8%)
Mar 2018
-
-$2.63 M(-48.1%)
-$12.63 M(-2.0%)
Dec 2017
-$12.89 M(+15.6%)
-$5.07 M(+165.3%)
-$12.89 M(+34.6%)
Sep 2017
-
-$1.91 M(-36.6%)
-$9.58 M(+3.9%)
Jun 2017
-
-$3.02 M(+4.1%)
-$9.22 M(-21.5%)
Mar 2017
-
-$2.90 M(+64.9%)
-$11.74 M(+5.2%)
Dec 2016
-$11.15 M(-7.3%)
-$1.76 M(+13.1%)
-$11.15 M(-2.9%)
Sep 2016
-
-$1.55 M(-71.9%)
-$11.48 M(-7.4%)
Jun 2016
-
-$5.53 M(+139.4%)
-$12.40 M(+9.8%)
Mar 2016
-
-$2.31 M(+10.8%)
-$11.30 M(-6.1%)
Dec 2015
-$12.03 M(+53.2%)
-$2.09 M(-15.6%)
-$12.03 M(-4.1%)
Sep 2015
-
-$2.47 M(-44.2%)
-$12.55 M(-10.5%)
Jun 2015
-
-$4.43 M(+45.2%)
-$14.02 M(+37.8%)
Mar 2015
-
-$3.05 M(+17.1%)
-$10.18 M(+29.6%)
Dec 2014
-$7.85 M(+26.2%)
-$2.60 M(-33.9%)
-$7.85 M(+28.2%)
Sep 2014
-
-$3.94 M(+574.3%)
-$6.12 M(+105.3%)
Jun 2014
-
-$584.40 K(-19.2%)
-$2.98 M(-17.6%)
Mar 2014
-
-$723.70 K(-17.4%)
-$3.62 M(+25.0%)
Dec 2013
-$6.22 M
-$875.90 K(+9.6%)
-$2.90 M(+43.4%)
Sep 2013
-
-$799.20 K(-34.5%)
-$2.02 M(+65.5%)
Jun 2013
-
-$1.22 M
-$1.22 M

FAQ

  • What is BioSig Technologies annual EBITDA?
  • What is the all time high annual EBITDA for BioSig Technologies?
  • What is BioSig Technologies annual EBITDA year-on-year change?
  • What is BioSig Technologies quarterly EBITDA?
  • What is the all time high quarterly EBITDA for BioSig Technologies?
  • What is BioSig Technologies quarterly EBITDA year-on-year change?
  • What is BioSig Technologies TTM EBITDA?
  • What is the all time high TTM EBITDA for BioSig Technologies?
  • What is BioSig Technologies TTM EBITDA year-on-year change?

What is BioSig Technologies annual EBITDA?

The current annual EBITDA of BSGM is -$28.15 M

What is the all time high annual EBITDA for BioSig Technologies?

BioSig Technologies all-time high annual EBITDA is -$6.22 M

What is BioSig Technologies annual EBITDA year-on-year change?

Over the past year, BSGM annual EBITDA has changed by -$1.18 M (-4.37%)

What is BioSig Technologies quarterly EBITDA?

The current quarterly EBITDA of BSGM is -$2.92 M

What is the all time high quarterly EBITDA for BioSig Technologies?

BioSig Technologies all-time high quarterly EBITDA is -$584.40 K

What is BioSig Technologies quarterly EBITDA year-on-year change?

Over the past year, BSGM quarterly EBITDA has changed by +$3.15 M (+51.94%)

What is BioSig Technologies TTM EBITDA?

The current TTM EBITDA of BSGM is -$16.18 M

What is the all time high TTM EBITDA for BioSig Technologies?

BioSig Technologies all-time high TTM EBITDA is -$1.22 M

What is BioSig Technologies TTM EBITDA year-on-year change?

Over the past year, BSGM TTM EBITDA has changed by +$11.97 M (+42.51%)